Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FYU-981 vs Febuxostat in Hyperuricemia
NCT03372200Phase 3Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dotinurad in hyperuricemia, sponsored by Mochida Pharmaceutical Co., Ltd.. Started Jan 2018; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT03372200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372200.